---
figid: PMC12125588__gr3
figtitle: Ginsenoside Rg1 in modulating myocardial hypertrophy and fibrosis
organisms:
- NA
organisms_ner:
- Homo sapiens
- Danio rerio
pmcid: PMC12125588
filename: gr3.jpg
figlink: /pmc/articles/PMC12125588/figure/F3/
number: F3
caption: 'Mechanisms of ginsenoside Rg1 in modulating myocardial hypertrophy and fibrosis.Ginsenoside
  Rg1 (Rg1) inhibits myocardial hypertrophy and fibrosis through Various signaling
  pathways. A. Inhibiting cardiac hypertrophy: Rg1 inhibits cardiac hypertrophy by
  activating SIRT1/PGC-1α to regulate FFA and energy metabolism in cardiomyocytes,
  inhibiting the TNF-α/NF-κB and Ca2+/Calpain-1 signaling pathways, and promoting
  Akt phosphorylation to suppress the MAPK signaling pathway. B. Modulating myocardial
  fibrosis: Rg1 regulates myocardial fibrosis by activating the SIRT1/PINK1/Parkin
  pathway, inhibiting the Ca2+/CaN/NFAT3 pathway, promoting MMP2 secretion, and reducing
  MMP9 secretion.Abbreviations: SIRT1, Sirtuin-1; PGC-1α, PPAR-gamma coactivator 1-alpha;
  FFA, free fatty acid; NF-κB, nuclear factor kappa B; MAPK, Mitogen-activated protein
  kinase; PINK1, PTEN-induced kinase 1; CaN, Calcineurin; NFAT3, Nuclear factor of
  activated T-cells 3'
papertitle: 'Roles and mechanisms of ginsenoside Rg1 in coronary artery disease: Progress
  and perspectives'
reftext: Lixiao Zhang, et al. J Ginseng Res. 2025 May;49(3).
year: '2025'
doi: 10.1016/j.jgr.2025.02.003
journal_title: Journal of Ginseng Research
journal_nlm_ta: J Ginseng Res
publisher_name: Elsevier
keywords: Cardioprotection | Coronary artery disease | Ginsenoside Rg1
automl_pathway: 0.9513721
figid_alias: PMC12125588__F3
figtype: Figure
redirect_from: /figures/PMC12125588__F3
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC12125588__gr3.html
  '@type': Dataset
  description: 'Mechanisms of ginsenoside Rg1 in modulating myocardial hypertrophy
    and fibrosis.Ginsenoside Rg1 (Rg1) inhibits myocardial hypertrophy and fibrosis
    through Various signaling pathways. A. Inhibiting cardiac hypertrophy: Rg1 inhibits
    cardiac hypertrophy by activating SIRT1/PGC-1α to regulate FFA and energy metabolism
    in cardiomyocytes, inhibiting the TNF-α/NF-κB and Ca2+/Calpain-1 signaling pathways,
    and promoting Akt phosphorylation to suppress the MAPK signaling pathway. B. Modulating
    myocardial fibrosis: Rg1 regulates myocardial fibrosis by activating the SIRT1/PINK1/Parkin
    pathway, inhibiting the Ca2+/CaN/NFAT3 pathway, promoting MMP2 secretion, and
    reducing MMP9 secretion.Abbreviations: SIRT1, Sirtuin-1; PGC-1α, PPAR-gamma coactivator
    1-alpha; FFA, free fatty acid; NF-κB, nuclear factor kappa B; MAPK, Mitogen-activated
    protein kinase; PINK1, PTEN-induced kinase 1; CaN, Calcineurin; NFAT3, Nuclear
    factor of activated T-cells 3'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - CASR
  - SIRT1
  - TNF
  - AKT1
  - AKT2
  - AKT3
  - NFKBIA
  - PINK1
  - RELA
  - CD40
  - ARHGEF7
  - ASCC1
  - H3P40
  - MMP9
  - MMP2
  - MAPK1
  - MAPK3
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK14
  - MAPK8
  - MAPK9
  - MAPK10
  - NFATC4
  - APRT
  - MFAP1
  - ATP8A2
  - casr
  - sirt1
  - tnfb
  - pink1
  - rela
  - nfkb1
  - mmp9
  - mmp2
  - Ginsenoside Rg1
  - TNF-a
  - CaN
  - FFA
---
